MedTrace Logo

CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products

NCT03153761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2018-04-10

No results posted yet for this study

Summary

This study will evaluate exposure to tobacco constituents from two moist snuff products, and provide a basis for comparing mouth-level exposure (MLE) in moist snuff users after use of each of the two moist snuff products.

Conditions

  • Tobacco Use

Interventions

OTHER

CSD170201AA

A moist snuff product

OTHER

CSD170201AB

A moist snuff product

Sponsors & Collaborators

  • Inflamax Research Limited

    collaborator UNKNOWN

  • RAI Services Company

    lead INDUSTRY

Principal Investigators

  • Nathan Segall, MD · Clinical Research Atlanta

  • Jason Miller, DO · Clinical Trials of Texas

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-08
Primary Completion
2017-11-17
Completion
2017-11-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03153761 on ClinicalTrials.gov